Purchase Order 75N92018P00122
Award Date 5/30/18
Potential Completion Date 5/29/19
Potential Value $376K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $177,991.20 firm fixed price purchase order to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic profiling of individuals of African descent. The order was issued directly under a solicitation, without the use of a set-aside. Metabolon provides metabolomics services and solutions to government agencies, leveraging its proprietary technology...
- Metabolon, Inc., a small disadvantaged business, was awarded a $244,993.28 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute. The purpose is to perform metabolomic profiling of individuals of African descent with metabolic disorders, including a focus on comparing the metabolic profiles of those with high versus low triglyceride levels. This award is part of the Africa America Diabetes study and aims to integrate multiple omics...
- This is a $40,500 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH), to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for a study comparing patients with lipodystrophy to patients with insulin receptor mutations. Metabolon is a leading provider of metabolomics solutions, offering advanced analytical methods and software for biomarker...
- This is a $226,695.00 firm fixed price purchase order awarded by the Northeast Area division of a civilian federal agency to Metabolon, Inc., a small disadvantaged business, for metabolomic profiling of plasma samples. The contract has a period of performance through May 15, 2024. Metabolon is a leading provider of metabolomics solutions and has served as a prime contractor on numerous federal contracts, supporting research initiatives across agencies like the VA, NIH, FDA, DoD, EPA, and USDA....
- This is a firm-fixed price purchase order awarded by the Department of Agriculture's Agricultural Research Service to Metabolon, Inc., a small disadvantaged business, for global metabolomics services. The contract has a potential value of $249,981.48 and a completion date of August 31, 2024. Metabolon provides specialized metabolomics analysis capabilities, including the identification and quantification of thousands of metabolites, to support biomedical research and regulatory science...
- This firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center to Metabolon, Inc., a small disadvantaged business, to provide specialized metabolomics analysis services. The $22,080.00 contract has a period of performance ending on September 22, 2024. Metabolon has served as a prime contractor on numerous federal contracts, providing metabolic profiling of biological samples to support research initiatives across agencies such as the...
- This is a $17,000 federal purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Metabolon, Inc., a small disadvantaged business, for metabolite analysis services. The contract is not set aside. Metabolon is a leading provider of metabolomics solutions that leverages proprietary technology to identify and quantify metabolites from biological samples. This contract supports NIDDK's research initiatives, such as the analysis of serum...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $118,993 firm fixed price purchase order to Metabolon, Inc. to conduct research analyzing the metabolomic profile associated with cardiometabolic traits in African Americans. The contract has a period of performance from August 29, 2023 through August 28, 2024. Under the solicitation seeking this analysis, Metabolon will leverage its expertise in metabolomics to provide...
- This is a $9,800 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Metabolon, Inc., a self-certified small disadvantaged business. The contract supports specialized metabolomics analysis services for various research programs, including those focused on veteran health, precision medicine, and environmental health impacts. Metabolon has been awarded multiple prime contracts and...
- This federal contract award was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business. The $24,948.00 firm fixed price purchase order is for a complex lipid panel analysis of 56 samples. The contract has no set-aside designation. Metabolon is a leading provider of specialized metabolomics analysis services, leveraging its proprietary platforms to support a wide range of federal...